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Expansion of activated Treg cells inversely correlates with clinical severity in septic neonates. 2 
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Capsule summary  24 
Our work contributes to the definition of a possibly protective role of Tregs in neonatal severe 25 
infections with particular attention to different molecules that may better define the phenotype and 26 
role of the Treg subset.  27 
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To the Editor:  37 
Current knowledge about regulatory T cells’ (Tregs) function in early life is very limited. Tregs 38 
represent a heterogeneous CD4+ T cell population addressed to maintain immunological self-39 
tolerance and immune homeostasis in various immune-mediated diseases including infectious 40 
processes. It is known that circulating CD4+CD25+ Tregs increase during septic shock in adult,1 41 
while very few data exist about Tregs in neonatal infections. The aim of our study was to analyse 42 
frequency/heterogeneity of Tregs in neonates with infectious and non-infectious systemic 43 
inflammatory response syndrome (SIRS) (see Table E1 in Online Repository). 44 
Firstly, we found that the percentage of FOXP3+CD127low Tregs within the gate of CD4+ T cells in 45 
mononuclear cells enriched from peripheral blood of neonates with sepsis or SIRS, as well as in 46 
neonatal (CTRLs) and paediatric (PED) controls, resulted similar in all cohorts (Fig.E1A-B) (see 47 
Figure E in Online Repository). However, when different subsets of Tregs were analysed 48 
(CD45RAhighFOXP3low resting [rest], CD45RAlowFOXP3high activated [act], and 49 
CD45RAlowFOXP3low non-suppressive [non] Tregs),2 (complete methodology available as Online 50 
Repository Methods) a marked increase of circulating actTregs was observed in both septic and 51 
SIRS neonates compared to CTRLs (Fig.E1A-C; Fig.1A). Using the EMA clinical and laboratory 52 
criteria to diagnose neonatal sepsis,3, 4 we developed a composite score in order to evaluate the 53 
clinical severity of enrolled patients. Importantly, an inverse correlation between actTreg frequency 54 
and clinical score was detected in septic neonates (Fig.1B), suggesting that actTregs may limit 55 
excessive sepsis-specific immunopathology. This hypothesis was supported by the evidence that 56 
CD39, a membrane ectonucleotidase hydrolysing ATP and ADP to AMP and ultimately 57 
contributing to the peculiar suppressive functions of Tregs,5 was expressed on Tregs more than 58 
Tconvs (Fig.E2A), and on actTregs more than restTregs or nonTregs (Fig.1C). To explore the 59 
mechanism of the high inter-individual variability in the CD39 expression on Tregs (Fig. 1D-E), we 60 
analysed the single-nucleotide polymorphism (SNP) rs10748643 (A vs G) within the ENTPD1 61 
gene.6 The allelic variation was closely related to CD39 levels in Tregs, but not in Tconvs; indeed, 62 
GG homozygous and/or AG heterozygous individuals showed a higher frequency of CD39+ Tregs 63 
compared to AA homozygous within each group (Fig.1D-E). In addition, a further increase of 64 
CD39+ Tregs, but not Tconvs (Fig.1E-F), was shown in both sepsis and SIRS neonates as compared 65 
with CTRLs, upon stratification by genotype, suggesting that both genetic signature and 66 
inflammatory milieu contribute to the CD39 overexpression. As control, we analysed the genetic 67 
contribution of the ENTPD1 SNP in determining CD39 levels in cord blood, a context mostly 68 
spared from T cell activation events (Fig.E2B-F).  69 
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To evaluate whether Tregs may modulate their phenotype during sepsis or SIRS, we quantified the 70 
expression of OX40, a receptor belonging to the tumour necrosis factor receptor family specifically 71 
up-regulated in highly suppressive tumour-infiltrating Tregs.7 OX40 was significantly more 72 
expressed in CD39+ compared to CD39–, principally within the gate of Tregs rather than Tconvs 73 
(Fig.E2G). Furthermore, a significant increment of OX40+ cells among CD39+ Tregs was detected 74 
in sepsis and even more in SIRS neonates as compared with CTRLs (Fig.2A). Notably, CTRLs, 75 
sepsis and SIRS neonates showed significantly higher OX40 expression in CD39+ than PED. Also 76 
in Tconvs, OX40 was markedly higher in CD39+ respect to CD39– cells (Fig.E2H), but at lower 77 
levels than Tregs (Fig.2A). These data suggest that Tregs, but not Tconvs, up-regulated OX40 78 
during both sepsis and non-infectious SIRS, especially in suppressive CD39+ cells accounting for 79 
the possible homeostatic role of Tregs in these pathologic conditions. Consistent with this 80 
hypothesis, the percentage of OX40+ Tregs was inversely correlated with the clinical score in septic 81 
neonates (Fig.2B), suggesting OX40 induction on Tregs as a protective mechanism in neonatal 82 
sepsis. Interestingly, OX40+ and CD39+ Tregs were more represented within Helioshigh than 83 
Helioslow cells irrespective of cohorts (Fig.E3A), strongly suggesting their belonging to a stable 84 
Treg population. Indeed, the transcription factor Helios has been described to distinguish thymic-85 
derived (committed/stable) FOXP3+ Treg from peripherally induced FOXP3+ Tregs.8  86 
To investigate whether particular cytokines may provide selective signals inducing OX40 up-87 
regulation during neonatal sepsis or SIRS, first we analysed the percentage of circulating T cells 88 
producing IFN- and/or TNF- by flow cytometry. Notably, IFN--single or IFN-γ/TNF--double 89 
producing T cells were poorly detectable in both CD4+ and CD8+ of neonates compared to PED and 90 
adult healthy donors (AD) (Fig.E3B-C), suggesting a neonatal incompetence to generate IFN--91 
mediated adaptive responses. Consistently with this hypothesis, T cells from all neonatal groups 92 
prevalently expressed a naïve phenotype (data not shown). By contrast, TNF-- producing T cells 93 
(CD4+ and CD8+) were similarly represented in all neonatal cohorts (Fig.E3B-C), as well as in PED 94 
and AD (Fig.E3B-C), despite an increased plasma TNF- level was detected in septic neonates 95 
(data not shown). Further studies are needed to investigate whether additional sources (monocytes, 96 
dendritic cells) may contribute to increase TNF- levels in septic neonates. Notably, we found that 97 
CD120b (TNFR2) was expressed at higher levels in Tregs than in Tconvs (Fig.E4A), as well as in 98 
CD39+ respect to CD39- Tregs (Fig.E4A), and even in septic or SIRS neonates significantly more 99 
than in CTRLs (Fig.2C). Interestingly, the percentage of OX40+ cells within CD39+ Tregs directly 100 
correlated with the percentage of CD120b+ cells (Fig.2D), as to support that the preferential OX40 101 
expression on CD39+ Tregs in vivo might be particularly due to the higher susceptibility to TNF- 102 
by CD39+CD120b+ Tregs, principally during neonatal sepsis and SIRS. In line with this finding, in 103 
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vitro experiments revealed that the overnight TNF- treatment of fresh PBMCs obtained from 104 
healthy CTRLs enhanced the level of OX40 expression at a greater degree in Tregs than in Tconvs 105 
(Fig.E4B). TNF- induced a significant OX40 up-regulation principally on CD39+ Tregs (Fig.2E), 106 
suggesting that CD39+ Tregs are particularly prone to up-regulate OX40.  107 
Then, based on the evidence of increased plasma levels of IL-33 (cytokine belonging to the IL-1 108 
superfamily) in SIRS neonates (data not shown), and of a previous report demonstrating an IL-33-109 
dependent up-regulation of OX40 on mouse Tregs in vitro,9 we investigated the role of this 110 
cytokine in activating Tregs in terms of OX40 up-regulation in vitro by using PBMCs from adult 111 
HDs. Interestingly, PBMCs treated with IL-33 were able to up-regulate OX40 expression at a 112 
significant higher level in total Tregs or CD39+ Tregs than in Tconv counterpart (Fig.E4C). 113 
Notably, a positive correlation between IL-33 plasma concentration and the percentage of OX40+ in 114 
total Tregs was observed in all neonatal cohorts (Fig.2F).  115 
Taken together, our data support the hypothesis that actTregs, especially OX40+ Tregs showing 116 
CD39+, Helios+, and CD120b+ phenotype, counteract excessive immunopathology in neonatal 117 
sepsis, and that their functions are modulated via prominent inflammatory cytokines, such as TNF-118 
 and IL-33, during infective and non-infective SIRS.  119 
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Figure legends 184 
Figure 1. Frequency of actTregs inversely correlates with septic score.  185 
(A) actTreg frequency estimated by FCM as the percentage of CD45RAlowFOXP3high Tregs among 186 
CD4+ T cells (CTRL=28; sepsis=10; SIRS=19; PED=21). *P<0.05, **P<0.01, by Mann-Whitney’s 187 
test, two-tailed. 188 
(B) Spearman’s correlation (r) between actTregs/CD4+ T cell percentage and clinical severity score 189 
in septic neonates. *P<0.05.  190 
(C) Representative FCM data (CTRL sample) showing CD45RA versus FOXP3 profile (left); 191 
overlay of CD39 MFI (right) of CD45RAlowFOXP3+ (actTreg), CD45RAhighFOXP3low (restTreg), 192 
CD45RAlowFOXP3- (nonTreg) subsets.  193 
(D) Representative FCM plots of CD39 vs FOXP3 expression in gated Tregs, showing the 194 
frequency of CD39+, according to AA or AG+GG genotypes in the ENTPD1 gene. 195 
(E) Frequency of CD39+ cells in gated Tregs in all cohorts according to AA or AG+GG genotypes 196 
in the ENTPD1 gene (CTRL=23; sepsis=10; SIRS=15; PED=21). *P<0.05, **P<0.01, ***P<0.005 197 
by Mann-Whitney’s test, two-tailed. 198 
(F) Frequency of CD39+ cells in gated Tconvs in all cohorts according to AA or AG+GG genotypes 199 
in the ENTPD1 gene (CTRL=23; sepsis=10; SIRS=15; PED=21). *P<0.05, **P<0.01, ***P<0.005 200 
by Mann-Whitney’s test, two-tailed.  201 
 202 
Figure 2. Frequency of OX40+ Tregs is up-regulated in sepsis and SIRS neonates and inversely 203 
correlates with septic score. 204 
(A) Frequency of OX40+ in subdivided CD39+ and CD39- Treg subsets in all groups (CTRL=32; 205 
sepsis=11; SIRS=20; PED=21). *P<0.05, **P<0.01, ***P<0.005, ****P<0.0001 by Mann-206 
Whitney’s test two-tailed and Wilcoxon’s matched-pairs test, two-tailed.   207 
 (B) Spearman’s correlation (r) between frequency of OX40+ Tregs and clinical severity score in 208 
septic neonates (Table I). *P<0.05. 209 
(C) PBMCs from healthy neonatal controls were cultured ON with or without TNF-. OX40 MFI 210 
was evaluated in Tregs and Tconvs. *P<0.05 by Paired T-test, two-tailed. 211 
(D) Frequency of CD120b+ cells in CD39+ and CD39- Tregs (CTRL=5; sepsis=6; SIRS=4).  212 
(E) Pearson’s correlation (r) between frequency of CD120b+ cells and OX40+ cells within CD39+ 213 
Tregs in all cohorts. **P<0.01. 214 
(F) Spearman’s correlation (r) between frequency of OX40+ Tregs and IL-33 plasma concentration 215 
in all cohorts. ***P<0.005. 216 
